Comprehensive Analysis of Adverse Events Associated with Gastric Peroral Endoscopic Myotomy: An International Multicenter Study.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
04 2021
Historique:
received: 30 12 2019
accepted: 15 04 2020
pubmed: 25 4 2020
medline: 3 7 2021
entrez: 25 4 2020
Statut: ppublish

Résumé

Gastric peroral endoscopic myotomy (G-POEM) has emerged as an effective management approach for patients with refractory gastroparesis. This study aims to comprehensively study the safety of G-POEM and describe the predictive factors of adverse events (AEs) occurrence. This study is a retrospective study involving 13 tertiary care centers (7 USA, 1 South America, 4 Europe, and 1 Asia). Patients who underwent G-POEM for refractory gastroparesis were included. Cases were identified by the occurrence of AEs. For each case, two controls were randomly selected and matched for age (± 10 years), gender, and etiology of gastroparesis. A total of 216 patients underwent G-POEM for gastroparesis. Overall, 31 (14%) AEs were encountered [mild 24 (77%), moderate 5 (16%), and severe 2 (6%)] during the duration of the study. The most common AE was abdominal pain (n = 16), followed by mucosotomy (n = 5) and capnoperitoneum (n = 4), and AEs were most commonly identified within the first 48-h post-procedure 18 (58%). The risk of adverse event occurrence was significantly higher for endoscopists with experience of < 20 G-POEM procedures (OR 3.03 [1.03-8.94], p < 0.05). G-POEM seems to be a safe intervention for refractory gastroparesis. AEs are most commonly mild and managed conservatively. Longitudinal mucosal incision, use of hook knife, use of clips for mucosal closure and endoscopist's experience with > 20 G-POEM procedures is significantly associated with decreased incidence of AEs.

Sections du résumé

BACKGROUND
Gastric peroral endoscopic myotomy (G-POEM) has emerged as an effective management approach for patients with refractory gastroparesis. This study aims to comprehensively study the safety of G-POEM and describe the predictive factors of adverse events (AEs) occurrence.
METHODS
This study is a retrospective study involving 13 tertiary care centers (7 USA, 1 South America, 4 Europe, and 1 Asia). Patients who underwent G-POEM for refractory gastroparesis were included. Cases were identified by the occurrence of AEs. For each case, two controls were randomly selected and matched for age (± 10 years), gender, and etiology of gastroparesis.
RESULTS
A total of 216 patients underwent G-POEM for gastroparesis. Overall, 31 (14%) AEs were encountered [mild 24 (77%), moderate 5 (16%), and severe 2 (6%)] during the duration of the study. The most common AE was abdominal pain (n = 16), followed by mucosotomy (n = 5) and capnoperitoneum (n = 4), and AEs were most commonly identified within the first 48-h post-procedure 18 (58%). The risk of adverse event occurrence was significantly higher for endoscopists with experience of < 20 G-POEM procedures (OR 3.03 [1.03-8.94], p < 0.05).
CONCLUSION
G-POEM seems to be a safe intervention for refractory gastroparesis. AEs are most commonly mild and managed conservatively. Longitudinal mucosal incision, use of hook knife, use of clips for mucosal closure and endoscopist's experience with > 20 G-POEM procedures is significantly associated with decreased incidence of AEs.

Identifiants

pubmed: 32328824
doi: 10.1007/s00464-020-07570-z
pii: 10.1007/s00464-020-07570-z
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1755-1764

Commentaires et corrections

Type : ErratumIn

Références

Parkman HP, Hasler WL, Fisher RS (2004) American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127:1592–1622
doi: 10.1053/j.gastro.2004.09.055
Cherian D, Parkman HP (2012) Nausea and vomiting in diabetic and idiopathic gastroparesis. Neurogastroenterol Motil 24(217–222):e103
Dudekula A, O'Connell M, Bielefeldt K (2011) Hospitalizations and testing in gastroparesis. J Gastroenterol Hepatol 26:1275–1282
doi: 10.1111/j.1440-1746.2011.06735.x
Tang DM, Friedenberg FK (2011) Gastroparesis: approach, diagnostic evaluation, and management. Dis Mon 57:74–101
doi: 10.1016/j.disamonth.2010.12.007
Hasler WL (2011) Gastroparesis: pathogenesis, diagnosis and management. Nat Rev Gastroenterol Hepatol 8:438–453
doi: 10.1038/nrgastro.2011.116
Sangnes DA, Softeland E, Biermann M, Gilja OH, Thordarson H, Dimcevski G (2016) Gastroparesis—causes, diagnosis and treatment. Tidsskr Nor Laegeforen 136:822–826
doi: 10.4045/tidsskr.15.0503
Jones MP, Maganti K (2003) A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 98:2122–2129
doi: 10.1111/j.1572-0241.2003.07721.x
Abrahamsson H (2007) Treatment options for patients with severe gastroparesis. Gut 56:877–883
doi: 10.1136/gut.2005.078121
Khashab MA, Stein E, Clarke JO, Saxena P, Kumbhari V, Chander Roland B, Kalloo AN, Stavropoulos S, Pasricha P, Inoue H (2013) Gastric peroral endoscopic myotomy for refractory gastroparesis: first human endoscopic pyloromyotomy (with video). Gastrointest Endosc 78:764–768
doi: 10.1016/j.gie.2013.07.019
Aghaie Meybodi M, Qumseya BJ, Shakoor D, Lobner K, Vosoughi K, Ichkhanian Y, Khashab MA (2019) Efficacy and feasibility of G-POEM in management of patients with refractory gastroparesis: a systematic review and meta-analysis. Endosc Int Open 7:E322–e329
doi: 10.1055/a-0812-1458
Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L (2013) Clinical guideline: management of gastroparesis. Am J Gastroenterol 108:18–37
doi: 10.1038/ajg.2012.373
Vosoughi K et al (2019) 644 Gastric peroral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: results from the first international prospective trial. Gastrointest Endosc. https://doi.org/10.1016/j.gie.2019.04.098
doi: 10.1016/j.gie.2019.04.098
Louazon T, Rivory J, Roman S, Mion F, Ponchon T, Pioche M (2016) Temporary dumping syndrome after gastric peroral endoscopic myotomy: should we control the glycemia? Endoscopy 48(Suppl 1 UCTN):E10–11
pubmed: 26800191
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71:446–454
doi: 10.1016/j.gie.2009.10.027
Benias PC, Khashab MA (2017) Gastric peroral endoscopic pyloromyotomy therapy for refractory gastroparesis. Curr Treat Options Gastroenterol 15:637–647
doi: 10.1007/s11938-017-0156-9
Gonzalez JM, Benezech A, Vitton V, Barthet M (2017) G-POEM with antro-pyloromyotomy for the treatment of refractory gastroparesis: mid-term follow-up and factors predicting outcome. Aliment Pharmacol Ther 46:364–370
doi: 10.1111/apt.14132
Mekaroonkamol P, Dacha S, Wang L, Li X, Jiang Y, Li L, Li T, Shahnavaz N, Sakaria S, LeVert FE, Keilin S, Willingham F, Christie J, Cai Q (2019) Gastric peroral endoscopic pyloromyotomy reduces symptoms, increases quality of life, and reduces health care use for patients with gastroparesis. Clin Gastroenterol Hepatol 17:82–89
doi: 10.1016/j.cgh.2018.04.016
Tao J, Patel V, Mekaroonkamol P, Luo H, Li B, Guan Q, Shen S, Chen H, Cai Q (2019) Technical aspects of peroral endoscopic pyloromyotomy. Gastrointest Endosc Clin N Am 29:117–126
doi: 10.1016/j.giec.2018.08.012
Geyl S, Legros R, Charissou A, Mesturoux L, Couquet CY, Carrier P, Brayette A, El-Ouafi Z, Loustaud-Ratti V, Sautereau D, Monteil J, Jacques J (2016) Peroral endoscopic pyloromyotomy accelerates gastric emptying in healthy pigs: proof of concept. Endosc Int Open 4:E796–799
doi: 10.1055/s-0042-108192
Chaves DM, Gusmon CC, Mestieri LH, de Moura EG, Veras MM, Pessorrusso FC, Sakai P (2014) A new technique for performing endoscopic pyloromyotomy by gastric submucosal tunnel dissection. Surg Laparosc Endosc Percutan Tech 24:e92–94
doi: 10.1097/SLE.0b013e31829cec0e
Jung Y, Lee J, Gromski MA, Kato M, Rodriguez S, Chuttani R, Matthes K (2015) Assessment of the length of myotomy in peroral endoscopic pyloromyotomy (G-POEM) using a submucosal tunnel technique (video). Surg Endosc 29:2377–2384
doi: 10.1007/s00464-014-3948-1
Jacques J, Pagnon L, Hure F, Legros R, Crepin S, Fauchais AL, Palat S, Ducrotte P, Marin B, Fontaine S, Boubaddi NE, Clement MP, Sautereau D, Loustaud-Ratti V, Gourcerol G, Monteil J (2019) Peroral endoscopic pyloromyotomy is efficacious and safe for refractory gastroparesis: prospective trial with assessment of pyloric function. Endoscopy 51:40–49
doi: 10.1055/a-0628-6639
Kahaleh M, Gonzalez JM, Xu MM, Andalib I, Gaidhane M, Tyberg A, Saumoy M, Baptista Marchena AJ, Barthet M (2018) Gastric peroral endoscopic myotomy for the treatment of refractory gastroparesis: a multicenter international experience. Endoscopy 50:1053–1058
doi: 10.1055/a-0596-7199
Li L, Spandorfer R, Qu C, Yang Y, Liang S, Chen H, Xue H, Cai Q (2018) Gastric per-oral endoscopic myotomy for refractory gastroparesis: a detailed description of the procedure, our experience, and review of the literature. Surg Endosc 32:3421–3431
doi: 10.1007/s00464-018-6112-5
Malik Z, Kataria R, Modayil R, Ehrlich AC, Schey R, Parkman HP, Stavropoulos SN (2018) Gastric per oral endoscopic myotomy (G-POEM) for the treatment of refractory gastroparesis: early experience. Dig Dis Sci 63:2405–2412
doi: 10.1007/s10620-018-4976-9
Shlomovitz E, Pescarus R, Cassera MA, Sharata AM, Reavis KM, Dunst CM, Swanstrom LL (2015) Early human experience with per-oral endoscopic pyloromyotomy (POP). Surg Endosc 29:543–551
doi: 10.1007/s00464-014-3720-6

Auteurs

Y Ichkhanian (Y)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA.

K Vosoughi (K)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA.

M Aghaie Meybodi (M)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA.

J Jacques (J)

Gastroenterology Department, Limoges University Hospital, 2 Avenue Martin Luther King, 87042, Rouen, France.

A Sethi (A)

Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA.

A A Patel (AA)

Division of Digestive and Liver Diseases, Columbia University Medical Center, New York, NY, USA.

A A Aadam (AA)

Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

J R Triggs (JR)

Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

A Bapaye (A)

Department of Digestive Diseases & Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India.

S Dorwat (S)

Department of Digestive Diseases & Endoscopy, Deenanath Mangeshkar Hospital and Research Center, Pune, Maharashtra, India.

P Benias (P)

Division of Gastroenterology, Zucker School of Medicine at Hofstra/Northwell, Long Island Jewish Medical Center, Northwell Health System, New Hyde Park, NY, USA.

D M Chaves (DM)

Gastroenterologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

M Barret (M)

Gastroenterology Unit, Cochin University Hospital, Université Paris Descartes, Paris, France.
Unité INSERM U1016, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

R J Law (RJ)

University of Michigan Health Care System, Ann Arbor, USA.

N Browers (N)

University of Michigan Health Care System, Ann Arbor, USA.

M Pioche (M)

Service d'Hépato-gastro-entérologie, Hôpital Edouard Herriot, CHU Lyon, Lyon, France.

P V Draganov (PV)

Division of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL, USA.

A Kotzev (A)

Clinic of Gastroenterology, University Hospital "Alexandrovska", Sofia, Bulgaria.

F Estremera (F)

Clinic of Gastroenterology, University Hospital "Alexandrovska", Sofia, Bulgaria.

E Albeniz (E)

Division of Gastroenterology, Complejo Hospitalario de Navarra, Pamplona, Spain.

M B Ujiki (MB)

Section of Minimally Invasive Surgery, Department of Surgery, NorthShore University Health System, Evanston, IL, USA.

Z M Callahan (ZM)

Section of Minimally Invasive Surgery, Department of Surgery, NorthShore University Health System, Evanston, IL, USA.

M I Itani (MI)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA.

O G Brewer (OG)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA.

M A Khashab (MA)

Division of Gastroenterology and Hepatology, Johns Hopkins Medical Institution, Baltimore, MD, USA. mkhasha1@jhmi.edu.
Division of Gastroenterology and Hepatology, Johns Hopkins Hospital, Sheikh Zayed Bldg, 1800 Orleans Street, Suite 7125G, Baltimore, MD, 21287, USA. mkhasha1@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH